Alls I am saying is this... Facts are 60% first line cure 57%...

Alls I am saying is this...
Facts are
60% first line cure
57% Third in line cure.

But at the end of the Ph2/3 Azer Cell, they won't compare this stat for Azer cell (57%) against the first in line stat (60% cure rate) and they wont make any conclusions there. The clinical trials for Azer cell have not been designed this way. (like it or not) it would be unethical and bad science to bring Azer cell to first in line.
The onclusion at the end of these trials - at best - will be this is a great option for those who have fallen off R -Chop (first in line) and auto Car-t (second in line). I think this is the best we can hope for in 18 months time - or whenever Azer Cell gets registration.

I don't think I am down-ramping or dis-ingenous, just trying to get a realistic lay of the land and what might happen. Because going forward over next 6 -12 months - you wanna have realistic expectations in-line with what actually might happen.

And if anyone can show me differences/reasons Azer_Cell would be so different to skip the queue or whatever, happy to hear.

Of course one person's realism is another ones downramping and so - on.